Mustafa Solak, MD es un médico que se graduó de la Facultad de Medicina de la Universidad de Hacettepe y completó residencias en el Hospital de Investigación y Enseñanza Sisli Etfal de Estambul y una beca en el Instituto del Cáncer de la Universidad de Hacettepe. Se especializa en cáncer de mama, cáncer de testículo, cáncer de ovario, cáncer de pulmón, cáncer de cabeza y cuello y cánceres gastrointestinales. También ha trabajado en el Centro de Cáncer MD Anderson de la Universidad de Texas, el Hospital de Capacitación Corum de la Universidad Hitit y el Hospital Medical Park.
Mostrar másMustafa Solak, MD es un médico que se graduó de la Facultad de Medicina de la Universidad de Hacettepe y completó residencias en el Hospital de Investigación y Enseñanza Sisli Etfal de Estambul y una beca en el Instituto del Cáncer de la Universidad de Hacettepe. Se especializa en cáncer de mama, cáncer de testículo, cáncer de ovario, cáncer de pulmón, cáncer de cabeza y cuello y cánceres gastrointestinales. También ha trabajado en el Centro de Cáncer MD Anderson de la Universidad de Texas, el Hospital de Capacitación Corum de la Universidad Hitit y el Hospital Medical Park.
Experience
2022 - 2023
Private Medipol Mega Hospitals Complex
2010 - 2010
Bezmialem Foundation University Faculty of Medicine
2010 - 2010
Bezmialem Foundation University Faculty of Medicine, Department of Ophthalmology
2001 - 2011
Vakif Gureba Training and Research Hospital, Department of Ophthalmology
2001 - 2011
Vakif Gureba Training and Research Hospital
2000 - 2001
Edirne Regional Hospital
2000 - 2001
Edirne Regional Hospital
Education
2000 Selçuk University, Ophthalmology
2000 SELÇUK UNIVERSITY, OPHTHALMOLOGY
1994 SELÇUK UNIVERSITY, FACULTY OF MEDICINE
1994 Selçuk University, Faculty of Medicine
Mostrar másExperience
2022 - 2023
Private Medipol Mega Hospitals Complex
2010 - 2010
Bezmialem Foundation University Faculty of Medicine
2010 - 2010
Bezmialem Foundation University Faculty of Medicine, Department of Ophthalmology
2001 - 2011
Vakif Gureba Training and Research Hospital, Department of Ophthalmology
2001 - 2011
Vakif Gureba Training and Research Hospital
2000 - 2001
Edirne Regional Hospital
2000 - 2001
Edirne Regional Hospital
Education
2000 Selçuk University, Ophthalmology
2000 SELÇUK UNIVERSITY, OPHTHALMOLOGY
1994 SELÇUK UNIVERSITY, FACULTY OF MEDICINE
1994 Selçuk University, Faculty of Medicine
Education
2019 İSTANBUL MEDİPOL UNIVERSITY, ASSOC. PROF. DR. - OPHTHALMOLOGY
2004 ISTANBUL PROF. DR. N. REŞAT BELGER BEYOĞLU E.A.H, SPECIALIZATION IN MEDICINE - OPHTHALMOLOGY
1999 ISTANBUL UNIVERSITY, ISTANBUL MEDICAL FACULTY
1999 ISTANBUL UNIVERSITY, ISTANBUL MEDICAL FACULTY
Publications
A. International Peer-Reviewed Journals:
Title: Comparison of different formulas for intraocular lens power calculation using a new optical biometer.
Title: Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: Ranibizumab versus aflibercept.
Title: Effect of aflibercept on persistent macular edema secondary to central retinal vein occlusion.
Title: Epithelium-off corneal cross-linking in progressive keratoconus: 6-year outcomes.
Authors: Eliaçık Mustafa, Karaman Erdur Sevil, Baltepe Altıok İnci, Gülkılık İbrahim Gökhan, Anıl Aslan Cemile, Kaya Faruk
Authors: Karabela Yunus, Eliaçık Mustafa, Kaya Faruk
Authors: Koçak İbrahim, Koçak Funda, Teker Bahri, Aydın Ali, Kaya Faruk, Hakan Baybora
Authors: Koçak İbrahim, Aydın Ali, Kaya Faruk, Koç Hacı
Authors: Baybora Hakan, Kaya Faruk, Koçak İbrahim, Karabela Yunus
Authors: Koçak İbrahim, Karabela Yunus, Karaman Mehmet, Kaya Faruk
B. Book Chapters:
Title: Corneal Cross-linking in Keratoconus.
Title: Intraocular Lens Power Calculation in Eyes with Previous Myopic Refractive Surgery.
Education
2019 İSTANBUL MEDİPOL UNIVERSITY, ASSOC. PROF. DR. - OPHTHALMOLOGY
2004 ISTANBUL PROF. DR. N. REŞAT BELGER BEYOĞLU E.A.H, SPECIALIZATION IN MEDICINE - OPHTHALMOLOGY
1999 ISTANBUL UNIVERSITY, ISTANBUL MEDICAL FACULTY
1999 ISTANBUL UNIVERSITY, ISTANBUL MEDICAL FACULTY
Publications
A. International Peer-Reviewed Journals:
Title: Comparison of different formulas for intraocular lens power calculation using a new optical biometer.
Title: Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: Ranibizumab versus aflibercept.
Title: Effect of aflibercept on persistent macular edema secondary to central retinal vein occlusion.
Title: Epithelium-off corneal cross-linking in progressive keratoconus: 6-year outcomes.
Authors: Eliaçık Mustafa, Karaman Erdur Sevil, Baltepe Altıok İnci, Gülkılık İbrahim Gökhan, Anıl Aslan Cemile, Kaya Faruk
Authors: Karabela Yunus, Eliaçık Mustafa, Kaya Faruk
Authors: Koçak İbrahim, Koçak Funda, Teker Bahri, Aydın Ali, Kaya Faruk, Hakan Baybora
Authors: Koçak İbrahim, Aydın Ali, Kaya Faruk, Koç Hacı
Authors: Baybora Hakan, Kaya Faruk, Koçak İbrahim, Karabela Yunus
Authors: Koçak İbrahim, Karabela Yunus, Karaman Mehmet, Kaya Faruk
B. Book Chapters:
Title: Corneal Cross-linking in Keratoconus.
Title: Intraocular Lens Power Calculation in Eyes with Previous Myopic Refractive Surgery.
El Dr. Raj es un oncólogo quirúrgico altamente experimentado con 19 años de experiencia y más de 50,000 cirugías de cáncer realizadas. Está involucrado en numerosos ensayos clínicos y tiene muchas publicaciones internacionales y nacionales en su haber. Se especializa en Oncología Quirúrgica Torácica y de Mama y se desempeña como profesor de Oncología Quirúrgica de Superespecialidad DNB y Cirugía de Mama en la Universidad de Ciencias de la Salud de Maharashtra. Su creencia es "agregar vida a los años" y mejorar la calidad de vida, no solo agregar años a la vida.
Mostrar másEl Dr. Raj es un oncólogo quirúrgico altamente experimentado con 19 años de experiencia y más de 50,000 cirugías de cáncer realizadas. Está involucrado en numerosos ensayos clínicos y tiene muchas publicaciones internacionales y nacionales en su haber. Se especializa en Oncología Quirúrgica Torácica y de Mama y se desempeña como profesor de Oncología Quirúrgica de Superespecialidad DNB y Cirugía de Mama en la Universidad de Ciencias de la Salud de Maharashtra. Su creencia es "agregar vida a los años" y mejorar la calidad de vida, no solo agregar años a la vida.
Education:
1995-1998 High School Kayseri Science High School
1998 Mehmet Akif Ersoy High School
1998-2004 Faculty of Medicine Hacettepe University Faculty of Medicine (Eng.)
2004- 2009 Hacettepe University Faculty of Medicine, Department of Eye Diseases (specialization)
Work Experience:
2009 - 2011 Yozgat State Hospital
2011 - 2019 Private Ankara Maya Eye Center
2020 - 2021 Private Eryaman Hospital Eye Clinic
Education:
1995-1998 High School Kayseri Science High School
1998 Mehmet Akif Ersoy High School
1998-2004 Faculty of Medicine Hacettepe University Faculty of Medicine (Eng.)
2004- 2009 Hacettepe University Faculty of Medicine, Department of Eye Diseases (specialization)
Work Experience:
2009 - 2011 Yozgat State Hospital
2011 - 2019 Private Ankara Maya Eye Center
2020 - 2021 Private Eryaman Hospital Eye Clinic
Education :
Istanbul University, Istanbul Faculty of Medicine September 2004 – July 2010
Istanbul University, Istanbul Faculty of Medicine, Department of Orthopaedics, Residency February 2011 - April 2011
Istanbul University, Istanbul Faculty of Medicine, Department of Ophthalmology, Residency August 2011 - March 2016
Thomas Jefferson University, Wills Eye Institute, Ocular Oncology Department, Observership August 2012 - September 2012
Turkish Health Ministry, Hakkari State Hospital, Ophthalmology Clinic, Eye M.D July 2016 – March 2018
Van Yuzuncu Yil University, Faculty of Medicine, Ophthalmology Department, Assistant Professor, March 2018 – October 2021
Van Yuzuncu Yil University, Faculty of Medicine, Ophthalmology Department, Associate Professor, October 2021 – December 2021
Istanbul Yeni Yuzyil University, Faculty of Medicine, Ophthalmology Department, Associate Professor, January 2022 – present
Educational Qualifications :
1. International Council of Ophthalmology (ICO) Basic Sciences assessment in ophthalmology examination passed on April 2017
2. International Council of Ophthalmology (ICO) Optics & Refraction examination passed on April 2017
3. International Council of Ophthalmology (ICO) Clinical Sciences in Ophthalmology examination passed on April 2018
4. Awarded for ICO-STAAR Surgical Three-Month Fellowship in Vitreo-Retina at the University of Kansas, Medical School, Dept. of Ophthalmology in Prairie Village, KS, USA under the supervision of Prof. Radwan Aijlan from April 6, 2020, to July 5, 2020.
5. International Council of Ophthalmology (ICO) Advanced Examination in Ophthalmology examination passed on July 2020.
6. United States Medical Licensing Examination (USMLE) Step 1 passed on January 7 2021 with 221 pts.
7. United States Medical Licensing Examination (USMLE) Step 2 CK passed on August 25 2021 with 214 pts.
Presentations & Posters :
1. 47th National Ophthalmology Congress, The effectiveness of photodynamic therapy on circumscribed choroidal hemangioma, Oral presentation, Ozer MD, Tuncer S, November 2013, Antalya, Turkey.
2. 48th National Ophthalmology Congress, Clinical features and treatment outcomes of primary ophthalmic rhabdomyosarcoma: Tertiary center experience, Ozer MD, Ulas MG, Tuncer S, Oral presentation, November 2014, Antalya, Turkey
3. 2015 ISOO Meeting, Long-term Outcome of Combined (Perilesional Injection and Topical) Interferon Alpha-2b Therapy in the Management of Ocular Surface Squamous Neoplasia, Tuncer S, Ozer MD, Oral presentation, June 2015, Paris, France
4. 49th National Ophthalmology Congress. Clinical presentation patterns of pediatric Vogt-Koyanagi-Harada syndrome and long-term follow-up results, Kiragi D, Ozer MD, Lider-Gezer M, Oray M, Tugal-Tutkun I, Oral presentation, November 2015, Istanbul, Turkey.
5. 49th National Ophthalmology Congress, Central corneal thickness and optic disc dimensions in glaucoma patients, Bayraktar S, Ozer MD, Izgi B, Poster, November 2015, Istanbul, Turkey.
6. 49th National Ophthalmology Congress, Analysis of retinal nerve fiber layer and choroidal thickness in patients with systemic sclerosis to identify a potential risk factor for normal-tension glaucoma, Ceylan E, Ozer MD, Ekinci M, Yilmaz YC, Poster, November 2015, Istanbul, Turkey.
7. 50th National Ophthalmology Congress, Treatment of age-related macular degeneration with intravitreal Ranibizumab: Real-life experience, Cebeci Z, Yilmaz YC, Ozer D, Kir N, Oral presentation, November 2016, Antalya, Turkey
8. 51st National Ophthalmology Congress, A rarely seen complication of cataract surgery: Endocapsular Hematoma, Ozer MD, Batur M, Artuç T, Seven E, Tekin S, Poster, November 2017, Antalya, Turkey
9. 52nd National Ophthalmology Congress, Nanophthalmos Wıth Macular Folds, Yavuzer B, Batur M, Seven E, Ozer MD, Poster, November 2018, Antalya, Turkey
10. 52nd National Ophthalmology Congress, Clinical Features and Treatment Methods of Orbital Cellulite Cases, Mesen S, Tekin S, Batur M, Duzenli U, Seven E, Ozer MD, Poster, November 2018, Antalya, Turkey
11. 52nd National Ophthalmology Congress, Case Series: Ocular Chemical Burns, Tekin S, Artuç T, Batur M, Ozer MD, Poster, November 2018, Antalya, Turkey
12. 52nd National Ophthalmology Congress, Sensory-Neural Hearing Loss affecting Low frequencies in Patients with Pseudoexfoliation, Ozer MD, Batur M, Duzenli U, Seven E, Tekin S, Poster, November 2018, Antalya, Turkey
13. 52nd National Ophthalmology Congress, Silicone tube intubation by Ritleng stent in children over two years of age with nasolacrimal duct obstruction, Ocal H, Seven E, Tekin S, Ozer MD, Batur M, Poster, November 2018, Antalya, Turkey
14. 52nd National Ophthalmology Congress, Cherry Red Spot Appearance in Macula and Alkaptonuria: A Case Report, Mesen S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turkey
15. 52nd National Ophthalmology Congress, A Rare Complication in Intravitreal Dexamethasone Implantation: Implant Migration to the Anterior Chamber, Gulbay S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turkey
16. 52nd National Ophthalmology Congress, Effect of Coenzyme Q10 Eye Drop on Corneal Wound Healing in Bacterial Keratitis Treatment, Batur M, Seven E, Tekin S, Ozer MD, Oral presentation, November 2018, Antalya, Turkey
17. 19th Euretina Congress, Effect of reduced production of aqueous humor on bacterial growth potential in rabbit eyes, Batur M, Ozer M, Tekin S, Oral presentation, September 2019, Paris, France
18. 53rd National Ophthalmology Congress, Evaluation of the clinical features of patients with hyphema due to blunt trauma, Seven E, Kebapci F, Tekin S, Batur M, Ozer MD, Oral presentation, November 2019, Antalya, Turkey
19. 53rd National Ophthalmology Congress, Adherence to drop therapy and the relationship of compliance with progression in glaucoma patients, Tekin S, Ocal H, Seven E, Batur M, Ozer MD, Poster, November 2019, Antalya, Turkey
20. 53rd National Ophthalmology Congress, Bilateral sudden-transient vision loss after central venous catheter removal, Altas AS, Batur M, Sayir F, Seven E, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turkey
21. 53rd National Ophthalmology Congress, Clinical Evaluation of Argon Laser Photocoagulation Therapy in Patients with Retinal Tears, Ocal H, Seven E, Batur M, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turkey
22. 53rd National Ophthalmology Congress, Macular damage due to laser epilation: a case report, Batur M, Ocal H, Ozer MD, Seven E, Tekin S, Poster, November 2019, Antalya, Turkey
23. 53rd National Ophthalmology Congress, Phototoxic Maculopathy Due to Extreme Usage of Infrared Illuminator Assembled Night Vision Handheld Scope, Ozer MD, Batur M, Seven E, Tekin S, Savasan M, Poster, November 2019, Antalya, Turkey
24. 54th National Ophthalmology Congress, Internal Ophthalmolplegia after Chickenpox Infection, Gedik AC, Ozer MD, Poster, November 2020, Virtual, Turkey.
Work Experience :
1. Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis (SARILNIUSATURN-Sanofi), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)
2. Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD-A&C-Servier), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)
3. A Randomized, Double-masked, Placebo-controlled Study of the Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD-B-Servier), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)
4. A 12-month, randomized, double-masked, sham-controlled, multicenter study to evaluate the efficacy and safety of 0.5 mg ranibizumab intravitreal injections due to vascular endothelial growth factor (VEGF) driven macular edema (RFB002-Novartis), Injection sub-investigator (Principle investigator: Prof. Dr. Nur Kir)
5. A Phase III multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of Lampalizumab administered intravitreally to patients with geographic atrophy secondary to age-related macular degeneration (GX29176-Roche), Photographer (Principle investigator: Prof. Dr. Nur Kir)
Selected as an active member of the Turkish Ophthalmological Association, Young Ophthalmologist Council, 2020 - present
Mostrar más
Education :
Istanbul University, Istanbul Faculty of Medicine September 2004 – July 2010
Istanbul University, Istanbul Faculty of Medicine, Department of Orthopaedics, Residency February 2011 - April 2011
Istanbul University, Istanbul Faculty of Medicine, Department of Ophthalmology, Residency August 2011 - March 2016
Thomas Jefferson University, Wills Eye Institute, Ocular Oncology Department, Observership August 2012 - September 2012
Turkish Health Ministry, Hakkari State Hospital, Ophthalmology Clinic, Eye M.D July 2016 – March 2018
Van Yuzuncu Yil University, Faculty of Medicine, Ophthalmology Department, Assistant Professor, March 2018 – October 2021
Van Yuzuncu Yil University, Faculty of Medicine, Ophthalmology Department, Associate Professor, October 2021 – December 2021
Istanbul Yeni Yuzyil University, Faculty of Medicine, Ophthalmology Department, Associate Professor, January 2022 – present
Educational Qualifications :
1. International Council of Ophthalmology (ICO) Basic Sciences assessment in ophthalmology examination passed on April 2017
2. International Council of Ophthalmology (ICO) Optics & Refraction examination passed on April 2017
3. International Council of Ophthalmology (ICO) Clinical Sciences in Ophthalmology examination passed on April 2018
4. Awarded for ICO-STAAR Surgical Three-Month Fellowship in Vitreo-Retina at the University of Kansas, Medical School, Dept. of Ophthalmology in Prairie Village, KS, USA under the supervision of Prof. Radwan Aijlan from April 6, 2020, to July 5, 2020.
5. International Council of Ophthalmology (ICO) Advanced Examination in Ophthalmology examination passed on July 2020.
6. United States Medical Licensing Examination (USMLE) Step 1 passed on January 7 2021 with 221 pts.
7. United States Medical Licensing Examination (USMLE) Step 2 CK passed on August 25 2021 with 214 pts.
Presentations & Posters :
1. 47th National Ophthalmology Congress, The effectiveness of photodynamic therapy on circumscribed choroidal hemangioma, Oral presentation, Ozer MD, Tuncer S, November 2013, Antalya, Turkey.
2. 48th National Ophthalmology Congress, Clinical features and treatment outcomes of primary ophthalmic rhabdomyosarcoma: Tertiary center experience, Ozer MD, Ulas MG, Tuncer S, Oral presentation, November 2014, Antalya, Turkey
3. 2015 ISOO Meeting, Long-term Outcome of Combined (Perilesional Injection and Topical) Interferon Alpha-2b Therapy in the Management of Ocular Surface Squamous Neoplasia, Tuncer S, Ozer MD, Oral presentation, June 2015, Paris, France
4. 49th National Ophthalmology Congress. Clinical presentation patterns of pediatric Vogt-Koyanagi-Harada syndrome and long-term follow-up results, Kiragi D, Ozer MD, Lider-Gezer M, Oray M, Tugal-Tutkun I, Oral presentation, November 2015, Istanbul, Turkey.
5. 49th National Ophthalmology Congress, Central corneal thickness and optic disc dimensions in glaucoma patients, Bayraktar S, Ozer MD, Izgi B, Poster, November 2015, Istanbul, Turkey.
6. 49th National Ophthalmology Congress, Analysis of retinal nerve fiber layer and choroidal thickness in patients with systemic sclerosis to identify a potential risk factor for normal-tension glaucoma, Ceylan E, Ozer MD, Ekinci M, Yilmaz YC, Poster, November 2015, Istanbul, Turkey.
7. 50th National Ophthalmology Congress, Treatment of age-related macular degeneration with intravitreal Ranibizumab: Real-life experience, Cebeci Z, Yilmaz YC, Ozer D, Kir N, Oral presentation, November 2016, Antalya, Turkey
8. 51st National Ophthalmology Congress, A rarely seen complication of cataract surgery: Endocapsular Hematoma, Ozer MD, Batur M, Artuç T, Seven E, Tekin S, Poster, November 2017, Antalya, Turkey
9. 52nd National Ophthalmology Congress, Nanophthalmos Wıth Macular Folds, Yavuzer B, Batur M, Seven E, Ozer MD, Poster, November 2018, Antalya, Turkey
10. 52nd National Ophthalmology Congress, Clinical Features and Treatment Methods of Orbital Cellulite Cases, Mesen S, Tekin S, Batur M, Duzenli U, Seven E, Ozer MD, Poster, November 2018, Antalya, Turkey
11. 52nd National Ophthalmology Congress, Case Series: Ocular Chemical Burns, Tekin S, Artuç T, Batur M, Ozer MD, Poster, November 2018, Antalya, Turkey
12. 52nd National Ophthalmology Congress, Sensory-Neural Hearing Loss affecting Low frequencies in Patients with Pseudoexfoliation, Ozer MD, Batur M, Duzenli U, Seven E, Tekin S, Poster, November 2018, Antalya, Turkey
13. 52nd National Ophthalmology Congress, Silicone tube intubation by Ritleng stent in children over two years of age with nasolacrimal duct obstruction, Ocal H, Seven E, Tekin S, Ozer MD, Batur M, Poster, November 2018, Antalya, Turkey
14. 52nd National Ophthalmology Congress, Cherry Red Spot Appearance in Macula and Alkaptonuria: A Case Report, Mesen S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turkey
15. 52nd National Ophthalmology Congress, A Rare Complication in Intravitreal Dexamethasone Implantation: Implant Migration to the Anterior Chamber, Gulbay S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turkey
16. 52nd National Ophthalmology Congress, Effect of Coenzyme Q10 Eye Drop on Corneal Wound Healing in Bacterial Keratitis Treatment, Batur M, Seven E, Tekin S, Ozer MD, Oral presentation, November 2018, Antalya, Turkey
17. 19th Euretina Congress, Effect of reduced production of aqueous humor on bacterial growth potential in rabbit eyes, Batur M, Ozer M, Tekin S, Oral presentation, September 2019, Paris, France
18. 53rd National Ophthalmology Congress, Evaluation of the clinical features of patients with hyphema due to blunt trauma, Seven E, Kebapci F, Tekin S, Batur M, Ozer MD, Oral presentation, November 2019, Antalya, Turkey
19. 53rd National Ophthalmology Congress, Adherence to drop therapy and the relationship of compliance with progression in glaucoma patients, Tekin S, Ocal H, Seven E, Batur M, Ozer MD, Poster, November 2019, Antalya, Turkey
20. 53rd National Ophthalmology Congress, Bilateral sudden-transient vision loss after central venous catheter removal, Altas AS, Batur M, Sayir F, Seven E, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turkey
21. 53rd National Ophthalmology Congress, Clinical Evaluation of Argon Laser Photocoagulation Therapy in Patients with Retinal Tears, Ocal H, Seven E, Batur M, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turkey
22. 53rd National Ophthalmology Congress, Macular damage due to laser epilation: a case report, Batur M, Ocal H, Ozer MD, Seven E, Tekin S, Poster, November 2019, Antalya, Turkey
23. 53rd National Ophthalmology Congress, Phototoxic Maculopathy Due to Extreme Usage of Infrared Illuminator Assembled Night Vision Handheld Scope, Ozer MD, Batur M, Seven E, Tekin S, Savasan M, Poster, November 2019, Antalya, Turkey
24. 54th National Ophthalmology Congress, Internal Ophthalmolplegia after Chickenpox Infection, Gedik AC, Ozer MD, Poster, November 2020, Virtual, Turkey.
Work Experience :
1. Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis (SARILNIUSATURN-Sanofi), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)
2. Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD-A&C-Servier), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)
3. A Randomized, Double-masked, Placebo-controlled Study of the Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD-B-Servier), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)
4. A 12-month, randomized, double-masked, sham-controlled, multicenter study to evaluate the efficacy and safety of 0.5 mg ranibizumab intravitreal injections due to vascular endothelial growth factor (VEGF) driven macular edema (RFB002-Novartis), Injection sub-investigator (Principle investigator: Prof. Dr. Nur Kir)
5. A Phase III multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of Lampalizumab administered intravitreally to patients with geographic atrophy secondary to age-related macular degeneration (GX29176-Roche), Photographer (Principle investigator: Prof. Dr. Nur Kir)
Selected as an active member of the Turkish Ophthalmological Association, Young Ophthalmologist Council, 2020 - present
"He has experience of over 10,000 surgical cases. He has published 48 scientific articles that are included in international and national scientific indexes, and these articles have been cited more than 250 times. He has also presented 28 papers in international and national scientific meetings. His professional interests are Cataract surgery (Femtosecond laser, Trifocal, EDOF, Multifocal, Toric intraocular lenses) Refractive surgery (Femtosecond laser, Excimer laser, LASIK, LASEK, PRK, SMILE) Oculoplastic surgery (Eyelid aesthetics, ptosis, entropion, ectropion, pterygium) Medical Retina (Macular degeneration) , Diabetic retinopathy, Retinal vascular occlusion, SSR) Glaucoma (Medical and surgical treatment) Strabismus and Amblyopia Filling and Botulinum toxin applications"
Mostrar más"He has experience of over 10,000 surgical cases. He has published 48 scientific articles that are included in international and national scientific indexes, and these articles have been cited more than 250 times. He has also presented 28 papers in international and national scientific meetings. His professional interests are Cataract surgery (Femtosecond laser, Trifocal, EDOF, Multifocal, Toric intraocular lenses) Refractive surgery (Femtosecond laser, Excimer laser, LASIK, LASEK, PRK, SMILE) Oculoplastic surgery (Eyelid aesthetics, ptosis, entropion, ectropion, pterygium) Medical Retina (Macular degeneration) , Diabetic retinopathy, Retinal vascular occlusion, SSR) Glaucoma (Medical and surgical treatment) Strabismus and Amblyopia Filling and Botulinum toxin applications"
La Dra. Shruti Kate es una oncóloga altamente capacitada y experimentada, que se especializa en el tratamiento de diferentes tipos de cáncer, incluidos los cánceres de pulmón, mama y ginecológico. Ha realizado una extensa investigación en el campo y fue la única ganadora de un premio de viaje desde la India en la Conferencia Mundial sobre el Cáncer de Pulmón de 2018.
Mostrar másLa Dra. Shruti Kate es una oncóloga altamente capacitada y experimentada, que se especializa en el tratamiento de diferentes tipos de cáncer, incluidos los cánceres de pulmón, mama y ginecológico. Ha realizado una extensa investigación en el campo y fue la única ganadora de un premio de viaje desde la India en la Conferencia Mundial sobre el Cáncer de Pulmón de 2018.
El Dr. X tiene una Licenciatura en Medicina de la Universidad de Mysore, India y un Doctorado en Medicina en radioterapia de la Universidad Hindú de Banaras, India. Es Diplomado de la Junta Nacional de Examen y es miembro de la Asociación de Oncología Radioterápica de la India, la Sociedad de Neurooncología, el Grupo de Oncología de Bangalore y la Asociación India de Oncología de Hipertermia.
Mostrar másEl Dr. X tiene una Licenciatura en Medicina de la Universidad de Mysore, India y un Doctorado en Medicina en radioterapia de la Universidad Hindú de Banaras, India. Es Diplomado de la Junta Nacional de Examen y es miembro de la Asociación de Oncología Radioterápica de la India, la Sociedad de Neurooncología, el Grupo de Oncología de Bangalore y la Asociación India de Oncología de Hipertermia.
El Dr. Ahmer Arif Shaikh es un MDS con 3 años de experiencia en oncología quirúrgica. Es experto en cáncer bucal, preservación de órganos y rehabilitación funcional de pacientes con cáncer bucal. También es competente en la realización de importantes cirugías maxilofaciales y de cabeza y cuello, y tiene una beca de formación en oncología quirúrgica de cabeza y cuello del Centro de Cáncer HCG Manavata, Nashik. También es un investigador con muchas publicaciones bajo su nombre.
Mostrar másEl Dr. Ahmer Arif Shaikh es un MDS con 3 años de experiencia en oncología quirúrgica. Es experto en cáncer bucal, preservación de órganos y rehabilitación funcional de pacientes con cáncer bucal. También es competente en la realización de importantes cirugías maxilofaciales y de cabeza y cuello, y tiene una beca de formación en oncología quirúrgica de cabeza y cuello del Centro de Cáncer HCG Manavata, Nashik. También es un investigador con muchas publicaciones bajo su nombre.
El Dr. Lalit es un cirujano oncológico altamente experimentado con 10 años de experiencia y más de 10,000 cirugías mayores realizadas. Ha realizado su MBBS de MIMER, Pune y MS de GMC Panaji. Tiene una beca de investigación en Oncología Quirúrgica y trabajó como co-investigador principal en múltiples investigaciones originales. Es conocido por su enfoque ético y amigable con el paciente, y su principal interés son las cirugías de cáncer mínimamente invasivas.
Mostrar másEl Dr. Lalit es un cirujano oncológico altamente experimentado con 10 años de experiencia y más de 10,000 cirugías mayores realizadas. Ha realizado su MBBS de MIMER, Pune y MS de GMC Panaji. Tiene una beca de investigación en Oncología Quirúrgica y trabajó como co-investigador principal en múltiples investigaciones originales. Es conocido por su enfoque ético y amigable con el paciente, y su principal interés son las cirugías de cáncer mínimamente invasivas.